Hyperhomocysteinemia is associated with aortic atheroma progression in stroke/ TIA patients

Frontiers in Neurology

Volumn NOV, Issue , 2010, Pages

  Sen, Souvik ^a   Reddy, P Leema ^b   Grewal, Raji P ^c   Busby, Marjorie ^d   Chang, Patricia ^d   Hinderliter, Alan ^d  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Neurogenetics Foundation   (United States)

^c Saint Francis Medical Ceter   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Aorta; Cardiac embolism; Cerebrovascular disease; Homocysteine; Stroke

Indexed keywords

EID: 84861769290     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2010.00131     Document Type: Article

References (43)

1. Adams, H. P.,Bendixen, B. H., Jap Kappelle, L., Biller, J., Love, B. B., Gordon, D. L., Marsh, E. E,, and The TOAST Investigators. (1993). Classification of subtypes of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke 24, 35-41.
2. Albers, G. W., Caplan, L. R., Easton, J. D., Fayad, P. B., Mohr, J. P., Saver, J. L., and Sherman, D. G. (2002). TIA Working Group. Transient ischemic attack - proposal for a new definition. N. Engl. J. Med. 347,1713-1716.
3. Amarenco, P., Cohen, A., Tzourio, C., Bertrand, B., Hommel, M., Besson, G., Chauvel, C., Touboul, P.-J., and Bousser,M.G. (1994). Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N. Engl. J. Med. 331, 1474-1479.
4. Bønaa, K. H., Njølstad, I., Ueland, P. M., Schirmer, H., Tverdal, A., Steigen, T., Wang, H., Nordrehaug, J. E., Arnesen, E., andRasmussen,K. (2006).NORVIT trial investigators. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N. Engl. J. Med. 354,1578-1588.
5. Cheitlin, M. D. Armstrong, W. F., Aurigemma, G. P., Beller, G. A., Bierman, E Z., Davis, J. L., Douglas, P. S., Faxon, D. P., Gillam, L. D., Kimball, T. R., Kussmaul, W. G., Pearlman, A. S., Philbrick, J. T., Rakowski, H., Thys, D. M., Antman, E. M., Smith, S. C. Jr, Alpert, J. S., Gregoratos, G., Anderson, J. L., Hiratzka, L. F., Hunt, S. A., Fuster, V., Jacobs, A. K., Gibbons, R. J., Russell, R. O., American College of Cardiology, American Heart Association, and American Society of Echocardiography. (2003). ACC/ AHA/ASE Guideline update for clinical application of echocardiography by the American College of Cardiology and American Heart Association Inc.
6. Coppola, A., Davi, G., De Stefano, V., Mancini, F. P., Cerbone, A. M., and Di Minno, G. (2000). Homocysteine, coagulation, platelet function, and thrombosis. Semin. Thromb. Hemost. 26,243-254.
7. Corti, R. (2006). Noninvasive imaging of atherosclerotic vessels by MRI for clinical assessment of the effectiveness of therapy. Pharmacol. Ther. 110,57-70.
8. Corti, R.,Fuster,V., Fayad, Z. A., Worthley, S. G., Helft, G., Chaplin, W. F., Muntwyler, J., Viles-Gonzalez, J. F., Weinberger, J., Smith, D. A., Mizsei, G., and Badimon, J. J. (2005). Effects of aggressive versus conventional lipid-lowering therapy by simvasta-tin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J. Am. Coll. Cardiol. 46,106-112.
9. Coull, B. M., Malinow, M. R., Beamer, N., Sexton, G., Nordt, F., and de Garmo, P. (1990). Elevated plasma homocyst(e) ine concentration as a possible independent risk factor for stroke. Stroke 21,572-576.
10. Daniel, W. G., Erbel, R., Kasper, W., Visser, C. A., Engberding, R., Sutherland, G. R., Grube, E., Hanrath, P., Maish, B., and Denning, K. (1991). Safety of transesophageal echocardiography: a multicenter survey of 10419 examinations. Circulation 83, 817-821.
11. Frosst, P., Blom, H. J., Milos, R., Goyette, P., Sheppard, C. A., Matthews, R. G., Boers, G. J., den Heijer, M., Kluijtmans, L. A., van den Heuvel, L. P., and Rozen, R. (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10,111-113.
12. Geraci, A., and Weinberger, J. (2000). Natural history of aortic arch athero-sclerotic plaque. Neurology 54, 749-751.
13. Hackam, D. G., Peterson, J. C., and Spence, J. D. (2000). What level of plasma homocyst(e)ine should be treated? Effect of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 micromol/L. Am. J.Hypertens. 13,105-110.
14. Howard, V. J., Sides, E. G., Newman, G. C., Cohen, S. N., Howard, G., Malinow, M. R., Toole, J. F., and Stability of Plasma Homocyst(e)ine in Acute Stroke Patients (SHASP) Study Investigators. (2000). Changes in plasma homocyst(e)ine in the acute phase after stroke. Stroke 33, 473-478.
15. Kaul, S., Zadeh, A. A., and Shah, P. K. (2006). Homocysteine hypothesis for atherothrombotic cardiovascular disease: not validated.J. Am. Coll. Cardiol. 48,914-923.
16. Khoury, Z., Rinat, C., Benhorin, J., Stern, S., and Keren, A. (1998). Quantification of atherosclerotic burden in the descending aorta by transesophageal echocardiography: inter- and intraob-server variability. Echocardiography 15, 59-66.
17. Konecky, N., Malinow, M. R., Tunick, P. A., Freedberg, R. S., Rosenzweig, B. P., Katz, E. S., Hess, D. L., Upson, B., Leung, B., Perez, J., and Kronzon, I. (1997). Correlation between plasma homocyst(e)ine and aortic atherosclerosis. Am. HeartJ. 133, 534-540.
18. Liapis, C., Kakisis, J., Papavassiliou, V., Ntanou, A., Kontopoulou, S., Kaperonis, E., Koumakis, K., and Gogas, J. (2000). Internal carotid artery stenosis: rate of progression Eur. J. Vasc. Endovasc. Surg. 19,111-117.
19. Lonn, E., Yusuf, S., Arnold, M. J., Sheridan, P., Pogue, J., Micks, M., McQueen, M. J., Probstfield, J., Fodor, G., Held, C., Genest, J. Jr, and Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. (2006). Heart outcomes prevention evaluation (HOPE) 2 investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N. Engl. J. Med. 354,1567-1577.
20. Malinow, M. R., Kang, S. S., Taylor, L. M., Wong, P. W. K., Coull, B., Inahara, T., Mukerjee, D., Sexton, G., and Upson, B. (1989). Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation 79,1180-1188.
21. Malinow, M. R., Nieto, F. J., Szklo, M., Chambless, L. E., and Bond, G. (1993). Carotid artery intimal-medial wall thickening and plasma homocysteine in asymptomatic adults. The Atherosclerosis risk in communities study. Circulation 87,1107-1113.
22. McNamara, R. L., Lima, J. A. C., Whelton, P. K., and Powe, N. R. (1997). Echocardiographic identification of cardiovascular sources of emboli to guide clinical management of stroke: a cost-effectiveness analysis. Ann. Intern. Med. 127, 775-787.
23. Montgomery. D. H., Ververis, J. J., McGorisk, G., Frohwein, S., and Martin, R. P. (1996). Natural history of severe atheromatous disease of the thoracic aorta: a transesophageal echocardiographic study. J. Am. Coll. Cardiol. 27, 95-101.
24. Olin, J. W., Fonseca, C., Childs, M. B., Piedmonte, M. R., Hertzer, N. R., and Young J. R. (1998). The natural history of asymptomatic moderate internal carotid artery stenosis by duplex ultrasound. Vasc. Med. 3,101-108.
25. Pistavos, C. E., Aggeli, K. I., Barbetseas, J. D., Skoumas, I. N., Lambrou, S. G., Frogoudaki, A. A., Stefanadis, C. I., and Toutouzas, P. K. (1998). Effect of pravastatin on thoracic aortic atherosclerosis in patients with heterozygous familial hypercholesterolemia. Am. J. Cardiol. 82,1484-1488.
26. Rumberger, J. A. (2001). Tomographic (plaque) imaging: state of the art. Am. J. Cardiol. 88, 66E-69E.
27. Schminke, U., Motsch, L., Griewing, B., Gaull, M., and Kessler, C. (2000). Three-dimensional power-mode ultrasound for quantification of progression of carotid artery atherosclerosis.J. Neurol. 247,106-111.
28. Sen, S., Hinderliter, A., Sen, P. K., Simmons, J.W., Beck, J., Offenbacher, S., Ohman, M.E., and Oppenheimer, S.M. (2007). Aortic arch atheroma progression and recurrent vascular events in stroke/TIA patients. Circulation 116, 928-935.
29. Sen, S., Oppenheimer, S. M., Lima, J. A. C., and Cohen, B. (2002). Risk factors for progression of aortic atheroma in stroke/TIA patient. Stroke 33, 930-935.
30. Sen, S., Wu, K., McNamara, R., Lima, J., Piantadosi, S., and Oppenheimer, S. M. (2000). Distribution, severity and risk factors for aortic atherosclerosis in cerebral ischemia. Cerebrovasc. Dis. 10,102-109.
31. Shimojo, M., Tsuda, N., Iwasaka, T., and Inada,M. (1991). Age-related changes in aortic elasticity determined by gated radionucleotide angiography in patients with systemic hypertension or healed myocardial infarcts and in normal subjects. Am. J. Cardiol. 68, 950-953.
32. Spence, J. D., Malinow, M. R., Barnett, P. A., Marian, A. J., Freeman, D., and Hegele R. A. (1999). Plasma homocyst(e)ine concentration, but not MTHFR genotype, is associated with variation in carotid plaque area. Stroke 30, 969-973.
33. Stampfer, M. J., Malinow, M. R., Willett, W. C., Newcomer, L. M., Upson, B., Ullman, D., Tishler, P. V., and Hennekens, C. H. (1992). A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 268, 877-881.
34. Subar, A. F., Thompson, F. E., Kipnis, V., Midthune, D., Hurwitz, P., McNutt, S., McIntosh, A., and Rosenfeld, S. (2001). Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires: the Eating at America's Table Study. Am. J. Epidemiol. 154, 1089-1099.
35. Takahashi, K., and Stanford, W. (2005). Multidetector CT of the thoracic aorta. Int. J. Cardiovasc. Imaging21, 141-153.
36. The French Study of Aortic Plaques in Stroke Group. (1996). Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N. Engl. J.Med. 334,1121-1221.
37. Ti, L. K., Mackensen, G. B., Grocott, H. P., Laskowitz, D. T., Phillips-Bute, B. G., Milano, C. A., Hilton, A. K., Newman, M. F., Mathew, J. P., and Neurologic Outcome Research Group. (2003). Neurologic outcome research group. Apolipoprotein E4 increases aortic atheroma burden in cardiac surgical patients. J. Thorac. Cardiovasc. Surg. 125,211-213.
38. Toole, J. F., Malinow, M. R., Chambless, L. E., Spence, J. D., Pettigrew, L. C., Howard, V. J., Sides, E. G., Wang, C. H., and Stampfer, M. (2004). Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the vitamin intervention for stroke prevention (VISP) randomized controlled trial. JAMA 291, 565-575.
39. Tribouilloy, C. M., Peltier, M., Iannetta Peltier, M. C., Trojette, F., Andrejak, M., and Lesbre, J. M. (2000). Plasma homocysteine and severity of thoracic aorta atherosclerosis. Chest 118, 1685-1689.
40. Tunick, P. A., and Kronzon, I. (2000). Atheromas of the thoracic aorta: clini-cal and therapeutic update. J.Am. Coll. Cardiol. 35, 545-554.
41. U.S. Department of Agriculture, Agricultural Research Service. (2001). USDA Nutrient Database for Standard Reference, Release 14. Nutrient Data Laboratory Home Page. Available at: http://www.nal.usda.gov/fnic/foodcomp
42. Yonemura, A., Momiyama, Y., Fayad, Z. A., Ayaori, M., Ohmori, R., Higashi, K., Kihara, T., Sawada, S., Iwamoto, N., Ogura, M., Taniguchi, H., Kusuhara, M., Nagata, M., Nakamur a, H., Tamai, S., and Ohsuzu F. (2005). Effect of lipid-lowering therapy with atorvas-tatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging. J. Am. Coll. Cardiol. 45, 733-742.
43. Zhang, J., and Yu, K. F. (1998). What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280, 1690-1691.